Suchergebnisse - "Baca, Sylvan C."

PubPharm (9)

1

Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential

enthalten in: Nature communications | 2022

von Kneppers, J. | Severson, T. | Siefert, J. | +19

CommentIn: Nat Rev Urol. 2023 Feb;20(2):65. - PMID 36600089

2

Drug-Induced Epigenomic Plasticity Reprograms Circadian Rhythm Regulation to Drive Prostate Cancer toward Androgen Independence

enthalten in: Cancer discovery | 2022

von Linder, S. | Hoogstraat, M. | Stelloo, S. | +33

CommentIn: Cancer Discov. 2022 Sep 2;12(9):2017-2019. - PMID 36052502

3

The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response

enthalten in: Cancer research | 2022

von Berchuck, J. | Adib, E. | Abou Alaiwi, S. | +29

4

HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancer

enthalten in: Nature genetics | 2022

von Lu, X. | Fong, K. | Gritsina, G. | +14

CommentIn: J Urol. 2022 Dec;208(6):1340-1342. - PMID 36154669

5

CREB5 reprograms FOXA1 nuclear interactions to promote resistance to androgen receptor-targeting therapies

enthalten in: eLife | 2022

von Hwang, J. | Arafeh, R. | Seo, J. | +18

6

A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer

enthalten in: Cell reports | 2022

von Tang, S. | Sethunath, V. | Metaferia, N. | +20

CommentIn: J Urol. 2022 Nov;208(5):1154-1155. - PMID 35975568

7

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer

enthalten in: Nature communications | 2021

von Baca, S. | Takeda, D. | Seo, J. | +38

8

Prostate cancer reactivates developmental epigenomic programs during metastatic progression

enthalten in: Nature genetics | 2020

von Pomerantz, M. | Qiu, X. | Zhu, Y. | +40

9

CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation

enthalten in: Cancer discovery | 2019

von Rasool, R. | Natesan, R. | Deng, Q. | +17

CommentIn: Cancer Discov. 2019 Nov;9(11):1490-1492. - PMID 31676563

1
[1]